We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.56B
AUM Growth
-$179M
Cap. Flow
-$104M
Cap. Flow %
-1.58%
Top 10 Hldgs %
11.86%
Holding
354
New
15
Increased
110
Reduced
195
Closed
8

Top Buys

Rank Stock Value
1
MASI
Masimo
MASI
+$26.8M
2
BIG
Big Lots, Inc.
BIG
+$24.1M
3
HMN icon
Horace Mann Educators
HMN
+$20.2M
4
DG icon
Dollar General
DG
+$19.9M
5
DHX icon
DHI Group
DHX
+$17.3M

Top Sells

Rank Stock Value
1
BLKB icon
Blackbaud
BLKB
+$30.3M
2
MLNX
Mellanox Technologies, Ltd.
MLNX
+$24.5M
3
MKTX icon
MarketAxess Holdings
MKTX
+$23.7M
4
CMC icon
Commercial Metals
CMC
+$19.5M
5
ICUI icon
ICU Medical
ICUI
+$18.1M

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Technology 16.27%
3 Healthcare 13.91%
4 Industrials 12.55%
5 Consumer Discretionary 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD
326
DELISTED
Du Pont De Nemours E I
DD
$353K 0.01%
5,807
+189
+3% +$12.7K
IDXX icon
327
Idexx Laboratories
IDXX
$43.9B
$346K 0.01%
5,400
-600
-10% -$41.5K
MCK icon
328
McKesson
MCK
$99.5B
$337K 0.01%
1,501
+50
+3% +$11.6K
BAC icon
329
Bank of America
BAC
$436B
$335K 0.01%
19,710
+1,608
+9% +$26.5K
NEE icon
330
NextEra Energy
NEE
$185B
$333K 0.01%
13,596
+3,096
+29% +$78.7K
SO icon
331
Southern Company
SO
$109B
$331K 0.01%
7,900
– –
DD icon
332
DuPont de Nemours
DD
$18.9B
$320K ﹤0.01%
2,466
+51
+2% +$6.61K
BHI
333
DELISTED
Baker Hughes
BHI
$320K ﹤0.01%
5,190
– –
NSC icon
334
Norfolk Southern
NSC
$77.1B
$316K ﹤0.01%
3,615
-925
-20% -$90.1K
INGR icon
335
Ingredion
INGR
$6.4B
$303K ﹤0.01%
3,800
-520
-12% -$41.8K
PH icon
336
Parker-Hannifin
PH
$124B
$297K ﹤0.01%
2,550
– –
EXPD icon
337
Expeditors International
EXPD
$22.4B
$274K ﹤0.01%
5,950
-1,225
-17% -$57.7K
NVO
338
Novo Nordisk
NVO
$220B
$266K ﹤0.01%
9,700
+2,200
+29% +$61.8K
UN
339
DELISTED
Unilever NV New York Registry Shares
UN
$262K ﹤0.01%
6,265
– –
HSIC icon
340
Henry Schein
HSIC
$9.64B
$242K ﹤0.01%
4,335
– –
ETN icon
341
Eaton
ETN
$155B
$240K ﹤0.01%
3,550
-400
-10% -$28.2K
NOC icon
342
Northrop Grumman
NOC
$77.8B
$239K ﹤0.01%
1,506
-250
-14% -$40K
IWM icon
343
iShares Russell 2000 ETF
IWM
$80.3B
$227K ﹤0.01%
+1,817
New +$227K
AGN
344
DELISTED
Allergan plc
AGN
$208K ﹤0.01%
686
-2,326
-77% -$694K
WBD icon
345
Warner Bros
WBD
$63.4B
$207K ﹤0.01%
6,231
-365
-6% -$12K
LLY icon
346
Eli Lilly
LLY
$1.07T
$205K ﹤0.01%
+2,450
New +$187K
BLKB icon
347
Blackbaud
BLKB
$1.59B
– –
-640,141
Closed -$30.3M
CMC icon
348
Commercial Metals
CMC
$7.53B
– –
-1,204,652
Closed -$19.5M
EPC icon
349
Edgewell Personal Care
EPC
$1.28B
– –
-13,603
Closed -$1.39M
ICUI icon
350
ICU Medical
ICUI
$4.04B
– –
-193,828
Closed -$18.1M
11 12 13
14
15

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q2 2015 Portfolio in Review

As of Q2 2015, Boston Trust Walden held 354 positions worth $6.56B, down 2.7% from $6.74B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boston Trust Walden's Q2 2015 filing shows 15 new, 110 increased, 195 reduced and 8 closed positions. Its largest new stake was Masimo: 749,049 shares worth $29M. The largest sale was Blackbaud, an estimated $30.3M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Boston Trust Walden's largest Q2 2015 buy was Masimo: 749,049 shares worth $29M.
  • Boston Trust Walden added most to Merck in Q2 2015, an estimated $16.8M increase.
  • Boston Trust Walden's biggest Q2 2015 reduction was Mellanox Technologies, Ltd., cutting an estimated $24.5M.
  • Boston Trust Walden fully exited Blackbaud in Q2 2015, selling an estimated $30.3M.
  • Boston Trust Walden's ten largest holdings make up 12% of its $6.56B portfolio in Q2 2015.
  • Boston Trust Walden opened 15 new positions and closed 8 in Q2 2015.
  • Boston Trust Walden's portfolio value fell 2.7% quarter-over-quarter to $6.56B.

Based on Boston Trust Walden's 13F filing for Q2 2015, filed 17 Jul 2015.